GENERIC NAME: clonidine (extended-release)
BRAND NAME: Kapvay (extended release)
DRUG CLASS AND MECHANISM: Kapvay is an oral medication used to treat attention deficit hyperactivity disorder (ADHD) in children and adolescents. This drug has been used to reduce blood pressure in adults for many years but has been approved for another indication by the FDA. Kapvay works by stimulating alpha-2 receptors in the brain. This may reduce hyperactivity symptoms by acting on parts of the brain that control emotion, attention and behavior. However the exact mechanism in treating ADHD is not known. The FDA approved Kapvay for pediatric patients aged 6–17 years in September 2010.
GENERIC AVAILABLE: Yes
PREPARATIONS: Tablets: 0.1, 0.2 mg (extended release)
STORAGE: Kapvay tablets should be stored at room temperature 20 C to 25 C (68 F to 77 F) and protected from light.
PRESCRIBED FOR: Kapvay is used to treat attention deficit/hyperactivity disorder (ADHD) in children and adolescents aged 6 to 17 years. Kapvay can be used alone or in combination with stimulant medications to treat ADHD.
DOSING: Kapvay tablets should be swallowed whole, and should not be broken, chewed or crushed before swallowing. Kapvay tablets can be taken with or without food.
The recommended starting dose is 0.1 mg tablet once a day at bedtime. Doses may be increased by 0.1 mg per day every 7 days. In this case, doses should be given twice a day (either split equally, or the higher dose given at bedtime). The maximum daily dose of Kapvay is 0.4 mg per day.
Quick GuideADHD Symptoms in Children
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Need help identifying pills and medications?
Use the pill identifier tool on RxList.